Bispecific CD20-directed CD3 T Cell Engager [EPC] - N0000194063

Pharmacologic Code	N0000194063
Pharmacologic Name	Bispecific CD20-directed CD3 T Cell Engager
Pharmacologic Uses	bispecific CD20-directed CD3 T-cell engager
Pharmacologic Concept	Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description	An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions: A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication. A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

The table contains 4 products whose active ingredient are classified under the same pharmacologic class Bispecific CD20-directed CD3 T Cell Engager [EPC].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	50242-125	Columvi	Non-Proprietary Name: Glofitamab	Solution, Concentrate	Intravenous	Genentech, Inc.	ACTIVE
	82705-010	Epkinly	Non-Proprietary Name: Epcoritamab-bysp	Injection, Solution	Subcutaneous	Genmab Us, Inc.	ACTIVE
	82705-002	Epkinly	Non-Proprietary Name: Epcoritamab-bysp	Injection, Solution	Subcutaneous	Genmab Us, Inc.	ACTIVE
	50242-127	Columvi	Non-Proprietary Name: Glofitamab	Concentrate	Intravenous	Genentech, Inc.	ACTIVE